156 related articles for article (PubMed ID: 36305832)
41. Performance and predictors of recruitment success in National Heart, Lung, and Blood Institute's cardiovascular clinical trials.
Pemberton VL; Evans F; Gulin J; Rosenberg E; Addou E; Burns KM; Gordon DJ; Pearson GD; Kaltman JR
Clin Trials; 2018 Oct; 15(5):444-451. PubMed ID: 30084662
[TBL] [Abstract][Full Text] [Related]
42. Results Reporting and Early Termination of Childhood Obesity Trials Registered on ClinicalTrials.gov.
Wang X; Long Y; Yang L; Huang J; Du L
Front Pediatr; 2022; 10():860610. PubMed ID: 35402346
[TBL] [Abstract][Full Text] [Related]
43. Discontinuation and nonpublication of interventional clinical trials conducted in ophthalmology.
Yilmaz T; Gallagher MJ; Cordero-Coma M; Gealy D; Loporchio S; Padula WV; Loporchio D; Statler B; Migliori M
Can J Ophthalmol; 2020 Feb; 55(1):71-75. PubMed ID: 31712042
[TBL] [Abstract][Full Text] [Related]
44. Association of trial registration with the results and conclusions of published trials of new oncology drugs.
Rasmussen N; Lee K; Bero L
Trials; 2009 Dec; 10():116. PubMed ID: 20015404
[TBL] [Abstract][Full Text] [Related]
45. Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010.
Califf RM; Zarin DA; Kramer JM; Sherman RE; Aberle LH; Tasneem A
JAMA; 2012 May; 307(17):1838-47. PubMed ID: 22550198
[TBL] [Abstract][Full Text] [Related]
46. The impact of the COVID-19 pandemic on early termination of ophthalmology clinical trials: A cross-sectional analysis of ClinicalTrials.gov.
Kakkilaya A; Hooda K; Kalva P; Dasara H; Janssen C; Vasireddy S; Ahmed A; Khan S; Kooner K
SAGE Open Med; 2023; 11():20503121231216592. PubMed ID: 38078203
[TBL] [Abstract][Full Text] [Related]
47. Neurology trial registrations on ClinicalTrials.gov between 2007 and 2018: A cross-sectional analysis of characteristics, early discontinuation, and results reporting.
Turner BE; Magnani CJ; Frolov A; Weeks BT; Steinberg JR; Huda N; Shah LM; Zuroff L; Gu BJ; Rasmussen H; Edwards JG; Save AV; Shen M; Ren M; Bryant BR; Ma Q; Feng AY; Liang AC; Santini VE
J Neurol Sci; 2021 Sep; 428():117579. PubMed ID: 34332371
[TBL] [Abstract][Full Text] [Related]
48. Unsuccessful trial accrual and human subjects protections: an empirical analysis of recently closed trials.
Carlisle B; Kimmelman J; Ramsay T; MacKinnon N
Clin Trials; 2015 Feb; 12(1):77-83. PubMed ID: 25475878
[TBL] [Abstract][Full Text] [Related]
49. The project data sphere initiative: accelerating cancer research by sharing data.
Green AK; Reeder-Hayes KE; Corty RW; Basch E; Milowsky MI; Dusetzina SB; Bennett AV; Wood WA
Oncologist; 2015 May; 20(5):464-e20. PubMed ID: 25876994
[TBL] [Abstract][Full Text] [Related]
50. Clinical Trials in Urology: Predictors of Successes and Failures.
Bandari J; Theisen KM; Maganty A; Davies BJ; Yabes JG; Jacobs BL
J Urol; 2020 Oct; 204(4):805-810. PubMed ID: 32267191
[TBL] [Abstract][Full Text] [Related]
51. Discontinuation and nonpublication of nasopharyngeal carcinoma clinical trials.
Huang H; Chen Z; Zhu M; Deng X; Yu L; Weng H; Yao Y; Hong H; Fang X; Wang Z; Tian Y; Huang H; Lin T
Oral Oncol; 2024 Jan; 148():106656. PubMed ID: 38065019
[TBL] [Abstract][Full Text] [Related]
52. Randomized controlled trials in pediatric patients had higher completion rates than adult trials: a cross-sectional study.
Dufetelle E; 't Jong GW; Kaguelidou F
J Clin Epidemiol; 2018 Aug; 100():53-60. PubMed ID: 29705092
[TBL] [Abstract][Full Text] [Related]
53. Challenges to accrual predictions to phase III cancer clinical trials: a survey of study chairs and lead statisticians of 248 NCI-sponsored trials.
Schroen AT; Petroni GR; Wang H; Thielen MJ; Sargent D; Benedetti JK; Cronin WM; Wickerham DL; Wang XF; Gray R; Cohn WF; Slingluff CL; Djulbegovic B
Clin Trials; 2011 Oct; 8(5):591-600. PubMed ID: 21878447
[TBL] [Abstract][Full Text] [Related]
54. Growth in eligibility criteria content and failure to accrue among National Cancer Institute (NCI)-affiliated clinical trials.
Peterson JS; Plana D; Bitterman DS; Johnson SB; Aerts HJWL; Kann BH
Cancer Med; 2023 Feb; 12(4):4715-4724. PubMed ID: 36398619
[TBL] [Abstract][Full Text] [Related]
55. Creating and Implementing a Principal Investigator Tool Kit for Enhancing Accrual to Late Phase Clinical Trials: Development and Usability Study.
Higgins KA; Thomas A; Soto N; Paulus R; George TJ; Julian TB; Hartson Stine S; Markham MJ; Werner-Wasik M
JMIR Cancer; 2022 Aug; 8(3):e38514. PubMed ID: 36006678
[TBL] [Abstract][Full Text] [Related]
56. A population study of clinical trial accrual for women and minorities in neuro-oncology following the NIH Revitalization Act.
Reihl SJ; Patil N; Morshed RA; Mehari M; Aabedi A; Chukwueke UN; Porter AB; Fontil V; Cioffi G; Waite K; Kruchko C; Ostrom Q; Barnholtz-Sloan J; Hervey-Jumper SL
Neuro Oncol; 2022 Aug; 24(8):1341-1349. PubMed ID: 34999844
[TBL] [Abstract][Full Text] [Related]
57. Registered clinical trials on addiction: a cross-sectional study on ClinicalTrials.gov.
Liu G; Chen L; Yang Y; Zhang Y; Luo S
J Addict Dis; 2022; 40(3):394-404. PubMed ID: 35348044
[TBL] [Abstract][Full Text] [Related]
58. Discontinuation of surgical versus nonsurgical clinical trials: an analysis of 88,498 trials.
Mouw TJ; Hong SW; Sarwar S; Fondaw AE; Walling AD; Al-Kasspooles M; DiPasco PJ
J Surg Res; 2018 Jul; 227():151-157. PubMed ID: 29804847
[TBL] [Abstract][Full Text] [Related]
59. Clinical Trials in Hepatopancreatobiliary Surgery: Assessing Trial Characteristics, Early Discontinuation, Result Reporting, and Publication.
Khachfe HH; Habib JR; Nassour I; Baydoun HA; Ghabi EM; Chahrour MA; Hallal AH; Jamali FR
J Gastrointest Surg; 2022 Aug; 26(8):1628-1636. PubMed ID: 35713764
[TBL] [Abstract][Full Text] [Related]
60. Factors Affecting Outcomes of Craniofacial Clinical Trials.
Halepas S; Lee KC; Nwokeji P; Castiglione C; Ferneini EM
J Craniofac Surg; 2021 Oct; 32(7):2484-2486. PubMed ID: 34705392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
